Blood cancer progression may be detectable years before diagnosis

Key Points:

• New research published in Cancer Discovery suggests DNA patterns can reveal the progression of certain blood cancers, specifically myeloproliferative neoplasms (MPNs), years before routine tests detect changes.
• The study tracked 30 MPN patients and found that stable disease correlated with stable DNA, while disease progression was often preceded by early DNA changes, indicating that genetic monitoring could provide early warnings.
• Some patients with "triple-negative" essential thrombocythemia showed no genetic signs of cancer, suggesting that some diagnosed cases might not require long-term cancer treatment.
• Researchers observed that common MPN medications like hydroxyurea leave identifiable DNA change patterns but do not appear to cause leukemia.
• Experts highlight the potential for precision medicine using genetic data to predict and monitor blood cancer risk years in advance, allowing for closer surveillance and earlier intervention before disease progression.